﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>American Journal of Medical Case Reports</journalTitle>
    <eissn>2374-216X</eissn>
    <publicationDate>2021-10-13</publicationDate>
    <volume>9</volume>
    <issue>12</issue>
    <startPage>730</startPage>
    <endPage>733</endPage>
    <doi>10.12691/ajmcr-9-12-18</doi>
    <publisherRecordId>AJMCR202191218</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Assessment and Treatment of Mucus Hypersecretion in COPD: A Case Study</title>
    <authors>
      <author>
        <name>Kami Whitney PA-C</name>
        <email>kamirenee@gmail.com</email>
        <affiliationId>1</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Arjun Medical Center, Gainesville, VA, USA</affiliationName>
    </affiliationsList>
    <abstract language="eng">Mucus hypersecretion is a debilitating feature of COPD that is often overlooked and under treated by clinicians despite its contribution to declining lung function and quality of life. This case study explores the use of the COPD Assessment Test in the evaluation of mucus hypersecretion and improvements in quality of life related to this symptom after the addition of guaifenesin as part of a comprehensive COPD care plan.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/9/12/18/ajmcr-9-12-18.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>COPD</keyword>
      <keyword>exacerbation</keyword>
      <keyword>mucus hypersecretion</keyword>
      <keyword>mucociliary clearance</keyword>
      <keyword>guaifenesin</keyword>
      <keyword>chronic bronchitis</keyword>
    </keywords>
  </record>
</records>